
DistalMotion
Removes the complexity out of robotic surgery by integrating the benefits of laparoscopy and robotics.
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | (8 %) | 4 % | 70 % | 29 % | 27 % | 61 % | 52 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Distalmotion is a startup that operates in the medical technology sector, specifically in the field of robotic surgery. The company's primary product is Dexter, a robotic system designed to assist surgeons in performing minimally invasive surgeries. Dexter is versatile and can be used in various surgical fields including upper and lower gastrointestinal surgery, general surgery, gynecology, and urology.
The company's business model is centered around providing on-demand robotics to hospitals. This means that rather than hospitals having to invest in expensive robotic systems, they can access Distalmotion's technology as and when needed. This approach not only makes robotic surgery more accessible to a wider range of hospitals but also helps to maintain efficiency and cost-effectiveness.
Distalmotion's clients are primarily hospitals and healthcare providers who are looking to enhance their surgical capabilities and offer their patients the best possible care. By providing advanced dexterity for complex surgical steps, Distalmotion's technology allows surgeons to perform procedures with greater precision and control.
The company generates revenue by charging for the use of its robotic systems. This could be on a per-use basis or through a subscription model where hospitals pay a regular fee to have ongoing access to the technology.
In conclusion, Distalmotion is a promising startup that is leveraging advanced robotics to revolutionize the field of minimally invasive surgery. Its innovative business model and cutting-edge technology position it well for success in the growing medical technology market.
Keywords: Robotic Surgery, Minimally Invasive Surgery, Medical Technology, On-Demand Robotics, Healthcare Providers, Dexter, Surgical Assistance, Efficiency, Cost-Effectiveness, Subscription Model.